Clinical trial
Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ IDE Clinical Study Protocol
NCT02224755 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ IDE Clinical Study Protocol
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 2, 2014
- Completion date
- March 26, 2019
- Enrollment
- 1,028 (actual)
- Sites
- 69
Conditions
As the registry lists them; a condition with its own page is linked.
advanced refractory left ventricular heart failure